Söndag 20 April | 16:49:54 Europe / Stockholm

Prenumeration

2025-04-14 16:08:00

Redeye retains its positive view of Carasent following the Q1 report. Carasent continues to execute in line with our expectations, and we are encouraged about the AI initiatives.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/